| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 1.000 | strong | 0.961 | 583 | 36 | 1989 | 2020 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
disease | 0.600 | strong | 0.927 | 79 | 4 | 2003 | 2020 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
disease | 0.400 | strong | 0.980 | 149 | 13 | 1983 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 1.000 | 32 | 0 | 1997 | 2019 | ||||||||
|
MCC regulator of WNT signaling pathway | 0.568 | 0.731 | 4.7E-16 |
|
disease | 0.400 | None | 1.000 | 17 | 1 | 1991 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 1993 | 2019 | ||||||||
|
nth like DNA glycosylase 1 | 0.623 | 0.615 | 5.7E-10 |
|
disease | 0.360 | None | 1.000 | 6 | 1 | 2015 | 2019 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
flavin containing dimethylaniline monoxygenase 3 | 0.638 | 0.500 | 6.5E-16 |
|
disease | 0.330 | None | 1.000 | 3 | 1 | 2004 | 2007 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
cytochrome P450 family 26 subfamily A member 1 | 0.619 | 0.577 | 8.4E-11 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1999 | 2017 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.981 | 369 | 0 | 1995 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.912 | 68 | 0 | 1992 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.100 | None | 0.949 | 39 | 2 | 1986 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.100 | None | 0.955 | 22 | 0 | 1993 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 1996 | 2017 | ||||||||
|
fibroblast activation protein alpha | 0.496 | 0.808 | 1.9E-28 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1990 | 2018 | ||||||||
|
APC regulator of WNT signaling pathway 2 | 0.582 | 0.654 | 1.00 |
|
disease | 0.100 | None | 0.944 | 17 | 0 | 1998 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1999 | 2016 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1999 | 2016 | |||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1998 | 2019 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.100 | None | 1.000 | 15 | 2 | 1993 | 2018 | ||||||||
|
axin 1 | 0.559 | 0.577 | 0.41 |
|
disease | 0.100 | None | 1.000 | 14 | 2 | 2002 | 2019 |